Nuohe Li (诺和力)诺和力
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字J20110026
生产企业Manufacturer
- 丹麦诺和诺德公司(丹麦)Chinese legal name: 丹麦诺和诺德公司(丹麦)
主要成分Active Ingredients
- 丙二醇Binger Chun
- 苯酚Ben Fen
- 注射用水Water for Injection (注射用水)
- 利拉鲁肽Lila Lutai
药物知识说明
国药准字J20110026是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：丙二醇Binger Chun、注射用水、苯酚Ben Fen。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：丙二醇-40961f6d成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 诺和力) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 丙二醇Binger Chun, 苯酚Ben Fen.
Explore other medicines containing the same ingredient: 丙二醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 诺和力Recorded Chinese name: 诺和力
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 3ml：18mg（预填充注射笔）Recorded Chinese description: 3ml：18mg（预填充注射笔）
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 丹麦诺和诺德公司(丹麦)Chinese legal name: 丹麦诺和诺德公司(丹麦)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字J20110026
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字J20110026
Manufacturer
Chinese legal name: 丹麦诺和诺德公司(丹麦)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字J20110026
生产企业
丹麦诺和诺德公司(丹麦)
适应症
1.适用于成人2型糖尿病患者控制血糖；|2.适用于单用二甲双胍或磺脲类药物最大可耐受剂量治疗后血糖仍控制不佳的患者，与二甲双胍或磺脲类药物联合应用。
用法用量
1.本品每日注射一次，可在任意时间注射，无需根据进餐时间给药。|2.本品经皮下注射给药，注射部位可选择腹部、大腿或者上臂。在改变注射部位和时间时无需进行剂量调整。然而，推荐本品于每天同一时间注射，应该选择每天最为方便的时间。
不良反应
尚不明确。
禁忌
对诺和力过敏者禁用。
注意事项
1.不得用于1型糖尿病患者或用于治疗糖尿病酮症酸中毒。|2.不得用于有甲状腺髓样癌（MTC)既往史或家族史患者以及2型多发性内分泌肿瘤综合征患者(MEN2)。
规格
3ml：18mg（预填充注射笔）
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.